PANews reported on June 3 that Neuralink has completed a $650 million Series E financing round, with investors including ARK Invest, DFJ Growth, Founders Fund, G42, Human Capital, Lightspeed, Qatar Investment Authority (QIA), Sequoia Capital, Thrive Capital, Valor Equity Partners, Vy Capital, etc. The funds will accelerate the clinical trials and product development of its brain-computer interface technology, and are committed to restoring autonomy for people with paralysis, language or visual impairments. Neuralink currently has 5 severely paralyzed patients who have achieved mind control of the device through its equipment, and has launched clinical trials in many top medical institutions around the world.